For most patients, treatment guidelines are fuzzy at best and, at worst, nonexistent, forcing clinicians to rely on educated guesswork. But thanks to advances in computation, data processing and telecommunication, that may be about to change.
Although the research was done in mice, the findings have possible implications for bone marrow transplants, more properly called hematopoietic stem cell transplants, in humans.
More than 300 health researchers from China and the United States convened at Stanford to share their knowledge of precision health, mobile health devices, population health, genomics and cancer.
At a Stanford Medicine Town Hall, three faculty members explored prospects for precision health — health care whose goal is to anticipate and prevent disease in the healthy and precisely diagnose and treat disease in the ill.
The five-year grant is the third award from the National Cancer Institute to fund the Center for Cancer Nanotechnology Excellence in Translational Diagnostics at Stanford.
Researchers discovered, in mice, the direct progenitors to coronary artery smooth muscle cells, the important component that encases the artery and gives it strength.
During the 2010 recession, pediatrician Lisa Chamberlain learned that 50 to 60 percent of families seen at the Ravenswood Family Health Center were struggling to pay rent and buy food.
